S-1 plus leucovorin versus S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin in patients with advanced gastric cancer: a randomised, multicentre, open-label, phase 2 trial-Reference-Cited by-同舟云学术

S-1 plus leucovorin versus S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin in patients with advanced gastric cancer: a randomised, multicentre, open-label, phase 2 trial

Published:2016-01 Issue:1 Volume:17 Page:99-108
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Hironaka Shuichi,Sugimoto Naotoshi,Yamaguchi Kensei,Moriwaki Toshikazu,Komatsu Yoshito,Nishina Tomohiro,Tsuji Akihito,Nakajima Takako Eguchi,Gotoh Masahiro,Machida Nozomu,Bando Hideaki,Esaki Taito,Emi Yasunori,Sekikawa Takashi,Matsumoto Shigemi,Takeuchi Masahiro,Boku Narikazu,Baba Hideo,Hyodo Ichinosuke

Publisher

Elsevier BV

Subject

Oncology

Reference19 articles.

1. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial;Koizumi;Lancet Oncol,2008

2. Phase III study comparing oxaliplatin plus S-1 with cisplatin plus S-1 in chemotherapy-naive patients with advanced gastric cancer;Yamada;Ann Oncol,2015

3. Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial;Kang;Ann Oncol,2009

4. Capecitabine and oxaliplatin for advanced esophagogastric cancer;Cunningham;N Engl J Med,2008

5. Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study;Boku;Lancet Oncol,2009

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A phase 1 study of biweekly nab-paclitaxel/oxaliplatin/S-1/LV for advanced upper gastrointestinal cancers: TCOG T1216 study;The Oncologist;2024-06-21

2. Development and Validation of a Cancer-Specific Early Death Prediction Model for Patients with Gastric Cancer with Liver Metastasis: Based on Machine Learning;2024-06-13

3. Nomogram based on clinical characteristics for predicting overall survival in gastric cancer patients with preoperative anemia;World Journal of Gastrointestinal Surgery;2023-07-27

4. Development and validation of nomograms for predicting overall survival and cancer-specific survival in elderly patients with locally advanced gastric cancer: a population-based study;BMC Gastroenterology;2023-04-11

5. The mechanism underlying resistance to 5‑fluorouracil and its reversal by the inhibition of thymidine phosphorylase in breast cancer cells;Oncology Letters;2022-07-15